Skip to main content
. 2015 Nov 1;33(48):6641–6649. doi: 10.1016/j.vaccine.2015.10.105

Fig. 2.

Fig. 2

A single intranasal immunisation of rAd5M or rAd5N confers protection against PVM challenge. Mice were immunised with 107 pfu (A) or 108 pfu (B) of either rAd5M, rAd5N or rAd5Z, or mock-immunised with PBS. Animals were challenged with PVM six weeks post immunisation and then weighed (left panels) and assessed for clinical signs of PVM disease (right panels) daily for the duration of the experiment. Dotted lines: mean weights or scores after the loss of one or more animals from the group. Other details as for Fig. 1.